Literature DB >> 18356474

Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features.

W S Bartynski1.   

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a neurotoxic state coupled with a unique CT or MR imaging appearance. Recognized in the setting of a number of complex conditions (preeclampsia/eclampsia, allogeneic bone marrow transplantation, organ transplantation, autoimmune disease and high dose chemotherapy) the imaging, clinical and laboratory features of this toxic state are becoming better elucidated. This review summarizes the basic and advanced imaging features of PRES, along with pertinent features of the clinical and laboratory presentation and available histopathology. Many common imaging/clinical/laboratory observations are present among these patients, despite the perception of widely different associated clinical conditions.

Entities:  

Mesh:

Year:  2008        PMID: 18356474      PMCID: PMC8118828          DOI: 10.3174/ajnr.A0928

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  117 in total

1.  Tacrolimus-related encephalopathy following allogeneic stem cell transplantation in children.

Authors:  Takahisa Kanekiyo; Junichi Hara; Yoshiko Matsuda-Hashii; Hiroyuki Fujisaki; Sadao Tokimasa; Akihisa Sawada; Keiko Kubota; Kuriko Shimono; Katsumi Imai; Keiichi Ozono
Journal:  Int J Hematol       Date:  2005-04       Impact factor: 2.490

2.  Immunosuppression-induced leukoencephalopathy from tacrolimus (FK506)

Authors:  S L Small; M B Fukui; G T Bramblett; B H Eidelman
Journal:  Ann Neurol       Date:  1996-10       Impact factor: 10.422

3.  CT appearance in hypertensive encephalopathy.

Authors:  Y L Kwong; Y L Yu; K S Lam; E Woo; J T Ma; C Y Huang
Journal:  Neuroradiology       Date:  1987       Impact factor: 2.804

4.  Neuroimaging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity.

Authors:  B A Appignani; R A Bhadelia; S C Blacklow; A K Wang; S F Roland; R B Freeman
Journal:  AJR Am J Roentgenol       Date:  1996-03       Impact factor: 3.959

Review 5.  The multiple organ dysfunction syndrome in cancer patients undergoing hematopoietic stem cell transplantation.

Authors:  W D Haire
Journal:  Semin Thromb Hemost       Date:  1999       Impact factor: 4.180

6.  Computerized tomographic appearance of hypertensive encephalopathy.

Authors:  D L Rail; G D Perkin
Journal:  Arch Neurol       Date:  1980-05

Review 7.  Neurotoxicity of immunosuppressive drugs.

Authors:  E F Wijdicks
Journal:  Liver Transpl       Date:  2001-11       Impact factor: 5.799

8.  Gemcitabine-associated posterior reversible encephalopathy syndrome: MR imaging and MR spectroscopy findings.

Authors:  M T Russell; A S Nassif; E D Cacayorin; E Awwad; W Perman; F Dunphy
Journal:  Magn Reson Imaging       Date:  2001-01       Impact factor: 2.546

9.  Reversible posterior leukoencephalopathy following organ transplantation. Description of two cases.

Authors:  G Lanzino; H Cloft; M K Hemstreet; K West; S Alston; M Ishitani
Journal:  Clin Neurol Neurosurg       Date:  1997-08       Impact factor: 1.876

10.  MR angiography of cerebral vasospasm in preeclampsia.

Authors:  T Ito; T Sakai; S Inagawa; M Utsu; T Bun
Journal:  AJNR Am J Neuroradiol       Date:  1995 Jun-Jul       Impact factor: 3.825

View more
  279 in total

1.  Seizure treatment in transplant patients.

Authors:  Paul W Shepard; Erik K St Louis
Journal:  Curr Treat Options Neurol       Date:  2012-08       Impact factor: 3.598

2.  Vasospasm is a significant factor in cyclosporine-induced neurotoxicity: case report.

Authors:  Hilde M H Braakman; Jan Lodder; Alida A Postma; Lambert F R Span; Werner H Mess
Journal:  BMC Neurol       Date:  2010-05-11       Impact factor: 2.474

3.  Multimodal imaging of reversible cerebral vasoconstriction syndrome: a series of 6 cases.

Authors:  C P Marder; M M Donohue; J R Weinstein; K R Fink
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-15       Impact factor: 3.825

4.  Reversible posterior leukoencephalopathy in a venomous snake (Bothrops asper) bite victim.

Authors:  Miguel E Delgado; Oscar H Del Brutto
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

5.  The posterior reversible encephalopathy syndrome in HIV infection.

Authors:  Sam Nightingale; Chris Wood; Jonathan Ainsworth
Journal:  BMJ Case Rep       Date:  2012-06-25

6.  Apparent diffusion coefficient map based on diffusion-weighted magnetic resonance imaging is useful in diagnosing the brainstem variant of reversible posterior leukoencephalopathy syndrome with uremia.

Authors:  Kenichi Katano; Yasushi Kakuchi; Akikatsu Nakashima; Katsuyuki Nakahama; Mitsuhiro Kawano
Journal:  Clin Exp Nephrol       Date:  2010-05-25       Impact factor: 2.801

7.  Acute hemorrhagic leukoencephalopathy associated with influenza A (H1N1) virus.

Authors:  Fodé Abass Cisse; Jean-Christophe Antoine; Sylvie Pillet; Guillemette Jousserand; Marie Reynaud-Salard; Jean-Philippe Camdessanche
Journal:  J Neurol       Date:  2010-10-06       Impact factor: 4.849

8.  Serious Visual (Ocular) Complications in Pre-eclampsia and Eclampsia.

Authors:  Thangappah Radha Bai Prabhu
Journal:  J Obstet Gynaecol India       Date:  2017-03-10

9.  Posterior reversible leukoencephalopathy syndrome secondary to hepatic transarterial chemoembolization with doxorubicin drug eluting beads.

Authors:  C Andrew Kistler; Joseph Caleb McCall; Saad Sultan Ghumman; Ijlal Akbar Ali; Ali A Siddiqui
Journal:  J Gastrointest Oncol       Date:  2014-04

10.  Acute Intermittent Porphyria and Posterior Reversible Encephalopathy Syndrome.

Authors:  Mansoor C Abdulla
Journal:  Ann Indian Acad Neurol       Date:  2020-12-08       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.